|
1
|
Rasheed MA, Tariq F, Afzal S and Mannanv
S: In silico analysis of fragile histidine triad involved in
regression of carcinoma. J Pak Med Assoc. 67:616–621.
2017.PubMed/NCBI
|
|
2
|
Sun G, Zhang C, Feng M, Liu W, Xie H, Qin
Q, Zhao E and Wan L: Methylation analysis of p16, SLIT2, SCARA5,
and Runx3 genes in hepatocellular carcinoma. Medicine (Baltimore).
96:e82792017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zekri AR, Bahnasy AA, Shoeab FE, Mohamed
WS, El-Dahshan DH, Ali FT, Sabry GM, Dasgupta N and Daoud SS:
Methylation of multiple genes in hepatitis C virus associated
hepatocellular carcinoma. J Adv Res. 5:27–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai JP, Wang YD, Zhang X and Xue HZ:
Expression of P16 and survivin in liver cancer and their clinical
significance. Zhonghua Gan Zang Bing Za Zhi. 25:778–780. 2017.(In
Chinese). PubMed/NCBI
|
|
5
|
Zhang C, Ye L, Guan S, Jin S, Wang W, Sun
S, Lee KH, Wei J and Liu B: Autoantibodies against p16
protein-derived peptides may be a potential biomarker for non-small
cell lung cancer. Tumour Biol. 35:2047–2051. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zaki SM, Abdel-Azeez HA, El Nagar MR,
Metwally KA and S Ahmed MM: Analysis of FHIT gene methylation in
egyptian breast cancer women: Association with clinicopathological
features. Asian Pac J Cancer Prev. 16:1235–1239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lassen P, Primdahl H, Johansen J,
Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG and
Overgaard J; Danish Head and Neck Cancer Group (DAHANCA), . Impact
of HPV-associated p16-expression on radiotherapy outcome in
advanced oropharynx and non-oropharynx cancer. Radiother Oncol.
113:310–316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shu R, He J, Wu C and Gao J: The
association between RARβ and FHIT promoter methylation and the
carcinogenesis of patients with cervical carcinoma: A
meta-analysis. Tumour Biol. 39:10104283177091262017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu GR, Qin WW, Li JP, Hua W, Meng YL, Chen
R, Yan B, Wang L, Zhang X, Jia LT, et al: HIV-TAT-fused FHIT
protein functions as a potential pro-apoptotic molecule in
hepatocellular carcinoma cells. Biosci Rep. 32:271–279. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fassan M, Rusev B, Corbo V, Gasparini P,
Luchini C, Vicentini C, Mafficini A, Paiella S, Salvia R, Cataldo
I, et al: Fhit down-regulation is an early event in pancreatic
carcinogenesis. Virchows Arch. 470:647–653. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim HK, Park JM, Chi KC, Lee EJ and Jeong
EM: Disappearance of serum methylated p16 indicates longer survival
in patients with gastric cancer. J Gastric Cancer. 13:157–163.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Czarnecka KH, Migdalska-Sęk M, Domańska D,
Pastuszak-Lewandoska D, Dutkowska A, Kordiak J, Nawrot E,
Kiszałkiewicz J, Antczak A and Brzeziańska-Lasota E: FHIT promoter
methylation status, low protein and high mRNA levels in patients
with non-small cell lung cancer. Int J Oncol. 49:1175–1184. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shan M, Zhang X, Liu X, Qin Y, Liu T, Liu
Y, Wang J, Zhong Z, Zhang Y, Geng J, et al: p16 and p53 play
distinct roles in different subtypes of breast cancer. PLoS One.
8:e764082013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tamoto A, Yashima K, Hosoda K, Yamamoto S,
Kawata S, Ikebuchi Y, Matsumoto K, Kawaguchi K, Harada K, Murawaki
Y, et al: Protein expression of fragile histidine triad and
cyclooxgenase-2 in serrated neoplasia of the colorectum. Oncol
Lett. 14:3683–3688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang JX, Han YP, Bai C and Li Q: Notch1/3
and p53/p21 are a potential therapeutic target for APS-induced
apoptosis in non-small cell lung carcinoma cell lines. Int J Clin
Exp Med. 8:12539–12547. 2015.PubMed/NCBI
|
|
17
|
Lv X, Ye G, Zhang X and Huang T: p16
Methylation was associated with the development, age, hepatic
viruses infection of hepatocellular carcinoma, and p16 expression
had a poor survival: A systematic meta-analysis (PRISMA). Medicine
(Baltimore). 96:e81062017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar R, Ghosh SK, Verma AK, Talukdar A,
Deka MK, Wagh M, Bahar HM, Tapkire R, Chakraborty KP and Kannan RR:
p16 expression as a surrogate marker for HPV infection in
esophageal squamous cell carcinoma can predict response to
neo-adjuvant chemotherapy. Asian Pac J Cancer Prev. 16:7161–7165.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seiwert TY: Ties that bind: p16 as a
prognostic biomarker and the need for high-accuracy human
papillomavirus testing. J Clin Oncol. 32:3914–3916. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu X, Wu G, Yao X, Hou G and Jiang F: The
clinicopathological significance and ethnic difference of FHIT
hypermethylation in non-small-cell lung carcinoma: A meta-analysis
and literature review. Drug Des Devel Ther. 10:699–709.
2016.PubMed/NCBI
|
|
21
|
Mai S, Welzel G, Ottstadt M, Lohr F,
Severa S, Prigge ES, Wentzensen N, Trunk MJ, Wenz F, von
Knebel-Doeberitz M, et al: Prognostic relevance of HPV infection
and p16 overexpression in squamous cell anal cancer. Int J Radiat
Oncol Biol Phys. 93:819–827. 2015. View Article : Google Scholar : PubMed/NCBI
|
